Journal of Neuroimmune Pharmacology

, Volume 3, Issue 1, pp 5–11 | Cite as

Inhibition of Toll-like Receptor Signaling in Primary Murine Microglia

  • Rajagopal N. Aravalli
  • Shuxian Hu
  • James R. Lokensgard
Original Article

Abstract

Microglial cells respond to the herpes simplex virus (HSV)-1 by producing proinflammatory cytokines and chemokines. After this inflammatory burst, these cells undergo apoptotic cell death. We have recently demonstrated that both virus-induced immune mediator production and apoptosis were induced through Toll-like receptor 2 (TLR2) signaling. Based upon these findings, we hypothesized that the inhibition of TLR2 signaling may serve as a means to alleviate excessive neuroinflammation. In the present study, we cloned four vaccinia virus (VV) proteins, which have been reported to disrupt either TLR signaling or NF-κB activation, and overexpressed them in HEK293T cells stably expressing murine TLR2 and in primary murine microglia. Using an NF-κB-driven luciferase reporter gene assay, we show that upon stimulation with HSV and Listeria monocytogenes, all four vaccinia proteins inhibited TLR2 signaling with different levels of inhibition in the TLR2-expressing cell line and primary microglia. We found similar results when microglial cells were stimulated with the TLR4 ligand LPS and the TLR9 ligand CpG ODN. Taken together, these data provide evidence that these VV proteins can function as inhibitors of TLR signaling in primary microglial cells.

Keywords

microglia toll-like receptors vaccinia virus NF-κB HSV 

References

  1. Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124:783–801PubMedCrossRefGoogle Scholar
  2. Alcami A (2003) Viral mimicry of cytokines, chemokines and their receptors. Nat Rev Immunol 3:36–50PubMedCrossRefGoogle Scholar
  3. Aloisi F (2001) Immune function of microglia. Glia 36:165–179PubMedCrossRefGoogle Scholar
  4. Aravalli RN, Hu S, Rowen TN, Palmquist J, Lokensgard JR (2005) Cutting edge: TLR2-mediated production of proinflammatory cytokines and chemokines by microglial cells in response to herpes simplex virus. J Immunol 175:4189–4193PubMedGoogle Scholar
  5. Aravalli RN, Hu S, Rowen TN, Gekker G, Lokensgard JR (2006) Differential apoptotic signaling in primary glial cells infected with herpes simplex virus 1. J Neurovirology 12:501–510CrossRefGoogle Scholar
  6. Aravalli RN, Peterson PK, Lokensgard JR (2007) Toll-like receptors in defense and damage of the central nervous system. J Neuroimmune Pharmacol 2:297–312PubMedCrossRefGoogle Scholar
  7. Bowie A, Kiss-Toth E, Symons JA, Smith GL, Dower SK, O’Neill LA (2000) A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling. Proc Natl Acad Sci U S A 97:10162–10167PubMedCrossRefGoogle Scholar
  8. Chao CC, Molitor TW, Hu S (1993) Neuroprotective role of IL-4 against activated microglia. J Immunol 151:1473–1481PubMedGoogle Scholar
  9. Dalpke AH, Schafer MK, Frey M, Zimmermann S, Tebbe J, Weihe E, Heeg K (2002) Immunostimulatory CpG-DNA activates murine microglia. J Immunol 168:4854–4863PubMedGoogle Scholar
  10. DiPerna G, Stack J, Bowie AG, Boyd A, Kotwal G, Zhang Z, Arvikar S, Latz E, Fitzgerald KA, Marshall WL (2004) Poxvirus protein N1L targets the I-kappaB kinase complex, inhibits signaling to NF-kappaB by the tumor necrosis factor superfamily of receptors, and inhibits NF-kappaB and IRF3 signaling by toll-like receptors. J Biol Chem 279:36570–36578PubMedCrossRefGoogle Scholar
  11. Finlay BB, McFadden G (2006) Anti-immunology: evasion of the host immune system by bacterial and viral pathogens. Cell 124:767–782PubMedCrossRefGoogle Scholar
  12. Harte MT, Haga IR, Maloney G, Gray P, Reading PC, Bartlett NW, Smith GL, Bowie A, O’Neill LA (2003) The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense. J Exp Med 197:343–351PubMedCrossRefGoogle Scholar
  13. Hochrein H, Schlatter B, O’Keefe M, Wagner C, Schmitz F, Schiemann M, Bauer S, Wagner H (2004) Herpes simplex virus type-1 induces IFN-α production via toll-like receptor 9-dependent and -independent pathways. Proc Natl Acad Sci U S A 101:11416–11421PubMedCrossRefGoogle Scholar
  14. Jung DY, Lee H, Jung BY, Ock J, Lee MS, Lee WH, Suk K (2005) TLR4, but not TLR2, signals autoregulatory apoptosis of cultured microglia: a critical role of IFN-beta as a decision maker. J Immunol 174:6467–6476PubMedGoogle Scholar
  15. Krug A, Luker GD, Barchet W, Lieb DA, Akira S, Colonna M (2004) Herpes simplex virus type 1 activates murine natural interferon-producing cells through Toll-like receptor 9. Blood 103:1433–1437PubMedCrossRefGoogle Scholar
  16. Kurt-Jones EA, Chan M, Zhou S, Wang J, Reed G, Bronson R, Arnold MM, Knipe DM, Finberg RW (2004) Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc Natl Acad Sci USA 101:1315–1320PubMedCrossRefGoogle Scholar
  17. Marques CP, Hu S, Sheng W, Cheeran MC, Cox D, Lokensgard JR (2004) Interleukin-10 attenuates production of HSV-induced inflammatory mediators by human microglia. Glia 47:358–366PubMedCrossRefGoogle Scholar
  18. Shisler JL, Jin XL (2004) The vaccinia virus K1L gene product inhibits host NF-κB activation by preventing IκBα degradation. J Virol 78:3553–3560PubMedCrossRefGoogle Scholar
  19. Stack J, Haga IR, Schroder M, Bartlett NW, Maloney G, Reading PC, Fitzgerald KA, Smith GL, Bowie AG (2005) Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence. J Exp Med 201:1007–1018PubMedCrossRefGoogle Scholar
  20. Streit WJ, Mrak RE, Griffin WST (2004) Microglia and neuroinflammation: a pathological perspective. J Neuroinflamation 1:14CrossRefGoogle Scholar
  21. Torres D, Barrier M, Bihl F, Quesniaux VJ, Maillet I, Akira S, Ryffel B, Erard F (2004) Toll-like receptor 2 is required for optimal control of Listeria monocytogenes infection. Infect Immun 72:2131–2139PubMedCrossRefGoogle Scholar
  22. Yamazaki S, Muta T, Matsuo S, Takeshige K (2005) Stimulus-specific induction of a novel nuclear factor-κB regulator, IκB-ζ, via Toll/Interleukin-1 receptor is mediated by mRNA stabilization. J Biol Chem 280:1678–1687PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Rajagopal N. Aravalli
    • 1
  • Shuxian Hu
    • 1
  • James R. Lokensgard
    • 1
  1. 1.Neuroimmunology Laboratory, Center for Infectious Diseases and Microbiology Translational ResearchUniversity of Minnesota Medical SchoolMinneapolisUSA

Personalised recommendations